Foster v. Summit Medical Systems, Inc.

610 N.W.2d 350, 2000 Minn. App. LEXIS 472, 2000 WL 622563
CourtCourt of Appeals of Minnesota
DecidedMay 16, 2000
DocketC5-99-1724
StatusPublished
Cited by5 cases

This text of 610 N.W.2d 350 (Foster v. Summit Medical Systems, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals of Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Foster v. Summit Medical Systems, Inc., 610 N.W.2d 350, 2000 Minn. App. LEXIS 472, 2000 WL 622563 (Mich. Ct. App. 2000).

Opinion

OPINION

HARTEN, Judge.

Appellants, insurers, challenge the summary judgment holding that respondents’ directors’ and officers’ liability insurance policies provided coverage for losses from securities lawsuits against respondents and from a Securities Exchange Commission (SEC) investigation involving respondents. Because we hold that the insurance policies’ retroactive date exclusions bar coverage for the losses from the underlying lawsuits and that the SEC investigation is *352 not a covered claim under the policies, we reverse and remand with directions that the district court enter summary judgment for appellants.

FACTS

1. The Underlying Actions

On June 21, 1995, respondent Summit Medical Systems, Inc. (Summit) filed a registration statement and' draft prospectus with the SEC, which resulted in its stock being first publicly traded in August 1995. In March 1997, Summit publicly announced that, due to accounting errors, its year-end revenue statements for 1994-1996 would be corrected downward by a total of $4,000,000 to $6,000,000. Thereafter, ten securities lawsuits were filed against Summit and the other respondents. The SEC also commenced an investigation of Summit.

The lawsuits were consolidated so that only two lawsuits, a class action suit and a suit by the Teachers’ Retirement System, went forward against respondents. The plaintiffs in these suits alleged that, respondents had plotted to inflate revenue and had artificially inflated Summit’s stock prices by disseminating false and misleading financial statements. The class-action plaintiffs specifically alleged that:

To make the Company attractive to its targeted investors, [respondents] sought ' to create the appearance of a Company with active, market appeal, strong growth potential and a consistent and steady revenue stream. In order to achieve this, [respondents] implemented a scheme and common course of conduct to inflate sales and revenue figures. Pursuant to the scheme, [respondents] instituted aggressive quarterly sales and revenue goals for the quarters preceding the June 1995 Initial Offering and for each quarter thereafter during the Class Period, and then consistently “met” those goals by recognizing revenue on transactions which did not qualify as sales under [generally accepted accounting principles] and were contrary to Summit Medical’s own revenue recognition policy.

Respondents had allegedly inflated revenue by recognizing letters of intent rather than completed sales contracts, even though the letters of intent did not always result in signed contracts, and by initiating sham transactions with other companies. These acts began before Summit filed its registration statement on June 21, 1995, and continued into 1996.

Respondents had disseminated the inflated revenue figures to the public in the June 21, 1995, registration statement, draft prospectus; and subsequent public statements. The plaintiffs alleged that, in these public statements, respondents made false and'material misstatements regarding their revenue and sales figures and their financial practices.

2. The Policies 1

Respondents sought insurance coverage for losses from these lawsuits under directors’ and officers’ liability insurance they had purchased from appellants. The policies covered the directors and officers for “Loss” resulting from any “Claim” made during the certificate period for a “Wrongful Act.” The policies also covered Summit for “Loss” resulting from a “Securities Action Claim” for a “Wrongful Act.”

Coverage for wrongful acts prior to the effective date of the insurance was limited by a retroactive date exclusion clause. At respondents’ request, the parties chose as the retroactive date, June 21, 1995, the date that the registration statement and draft prospectus were filed. The exclusion clause bars coverage for any claim arising out of “any Wrongful Act actually or allegedly committed prior to June 21, 1995,” or *353 interrelated wrongful acts committed thereafter.

Appellants brought an action for a declaration of no coverage for the lawsuits because of the retroactive date exclusion clause and for the SEC investigation because of the policy definition of “Securities Action Claim.” Following cross-motions for summary judgment, the district court granted summary judgment to respondents, holding that the wrongful act was the public dissemination of improper revenue figures, which occurred after the retroactive date and that the SEC investigation constituted a claim under the policies. This appeal followed.

ISSUES

1. Does the retroactive date exclusion bar coverage for the lawsuits against respondents?

2., Does the SEC investigation constitute a covered “Securities Action Claim” under the policies?

ANALYSIS

“Insurance coverage issues and the interpretation of insurance contract language are questions of law, reviewed de novo.” Jenoff, Inc. v. New Hampshire Ins. Co., 558 N.W.2d 260, 262 (Minn.1997). In interpreting insurance contracts, the court must ascertain and give effect to the intentions of the parties as reflected in the terms of the insurance contract. Id. If policy language is unambiguous, there is no reason for construction, and the court must “attribute the usual and accepted meaning” to the language. American Commerce Ins. Brokers, Inc. v. Minnesota Mut. Fire & Cas. Co., 551 N.W.2d 224, 227-28 (Minn.1996).

1. Retroactive Date Exclusion

The policies here exclude coverage for claims

based upon, arising out of, directly or indirectly resulting from or in consequence of, or in any way involving:
(1) any Wrongful Act actually or allegedly committed prior to June 21, 1995, or
(2) any Wrongful Act occurring on or subsequent to June 21, 1995 which, together with a Wrongful Act occurring prior to such date would constitute Interrelated Wrongful Acts.

The “Interrelated Wrongful Acts” policy language is broad and encompasses the acts in question. See Faber v. Roelofs, 311 Minn. 428, 436, 250 N.W.2d 817, 822 (1977) (the phrase “arising out of’ is broad). The policies defined “Wrongful Act” in relevant part as

any actual or alleged error, omission, misstatement, misleading statement, neglect, breach of duty or negligent act by any.of the Directors and Officers, while acting solely in their capacity as a director or officer of the Company.

The allegations that respondents improperly recognized revenue from letters of intent and sham transactions are alleged errors, breaches of duty, or negligent acts. Thus, the acts of improperly recognizing revenue are “Wrongful Acts.”

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
610 N.W.2d 350, 2000 Minn. App. LEXIS 472, 2000 WL 622563, Counsel Stack Legal Research, https://law.counselstack.com/opinion/foster-v-summit-medical-systems-inc-minnctapp-2000.